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Introduction {#sec1}
============

Skeletal movement is facilitated by synovial joints comprising articular cartilage encased in a capsule. Healthy articular cartilage minimizes friction and shock impacts, but wears with aging, and repair is inefficient ([@bib14]). Tissue repair involves the recruitment/activation of local progenitor cells, often recapitulating cellular differentiation similar to embryonic development. Synovial joints form through dedifferentiation of chondrocytes at the site of future joints ([@bib2]), defined as "interzones," marked by early expression of *Gdf5* and *Wnt9a* ([@bib11], [@bib12]), with progenitor properties ([@bib18], [@bib19]). Studies using *Gdf5-*Cre ([@bib18], [@bib27]) and inducible *Gdf5*-CreER^T2^ mice ([@bib5], [@bib30]) confirmed *Gdf5*-expressing cells contribute to the formation of articular chondrocytes and other joint-related cells. Furthermore, expansion of *Gdf5*^+^ cells in the interzone can come from recruitment of surrounding *Sox9*^+^/*Gdf5*-mesenchymal cells ([@bib30]). Regional localization of *Gdf5*^+^ cells (central or peripheral) in the interzone may influence differentiation of joint cell lineages ([@bib5]). Thus, the origin, timing, and location of interzone cells may determine cell fate in the joint tissues.

*Lgr5*, a member of the G-protein-coupled receptor family and a Wnt signaling target gene, is a stem cell marker for highly proliferative progenitor cells in the small intestine, colon, hair follicle, mammary gland, and ovary ([@bib20]). Collagen XXII (COLXXII), encoded by the *Col22a1* gene, is an extracellular matrix (ECM) protein localized at the articular cartilage-synovial fluid junction ([@bib17]). Its function is not well understood. A role as a negative regulator of chondrocyte hypertrophy through interacting with β1-integrin was proposed ([@bib36]). Here, we identify a population of *Lgr5*-expressing cells in the interzone of developing joints that contribute to the formation of the articular cartilage, cruciate ligaments, and meniscus. We show that *Col22a1* is expressed by *Lgr5*^+^ interzone cells prior to the cavitation process, supporting a lineage progression from *Lgr5*^+^ interzone cells to *Lgr5*^+^/*Col22a1*^+^ double-positive cells as committed progenitors for *Col22a1*^+^ juvenile chondrocytes at the articular surface.

Results {#sec2}
=======

*Lgr5* as a Novel Marker for Distinct Cells in Developing Synovial Joints {#sec2.1}
-------------------------------------------------------------------------

As interzone cells are progenitor cells, we screened these cells with a panel of stem cell markers and detected *Lgr5* expression by qRT-PCR ([Figure S1](#mmc1){ref-type="supplementary-material"}). Using *GFP* expression in *Lgr5-eGFP-IRES-CreER*^*T2*^ (Lgr5-GFP) mice, we confirmed *Lgr5* as a marker of interzone cells. *Lgr5-GFP* is a null allele, with *GFP* expression replacing *Lgr5* ([@bib1]). Mice heterozygous for this allele are normal and viable, while homozygous mice die perinatally ([@bib1]). However, we observed no abnormalities in limb development or synovial joint formation in homozygotes ([Figure S2](#mmc1){ref-type="supplementary-material"}). All analyses of *Lgr5/GFP* expression in synovial joints were carried out in mice heterozygous for this allele. Digit joints develop proximodistally, providing information on progression. By whole-mount analysis of Lgr5-GFP mice, we detected GFP in digit joints from embryonic day 13.5 (E13.5) to E18.5 ([Figure 1](#fig1){ref-type="fig"}A). At E13.5, the proximal M/P1 joint is clearly positive for GFP, whereas the P1/P2 joints show only a faint signal and no signal for the P2/P3 joints ([Figure 1](#fig1){ref-type="fig"}A), which was confirmed by histological analysis ([Figure 1](#fig1){ref-type="fig"}B). In the M/P1 joint of digit III, signal can be detected at E13.5 as a "salt and pepper" pattern in cells of the interzone, which becomes more intense and uniformly distributed in the center of the interzone from E14.5. With cavitation, *Lgr5*^+^ cells are detected in the flanking regions of future articular cartilage, and the intensity and number of expressing cells decrease substantially.Figure 1Expression of *Lgr5* in the Developing Digit and Knee Joints(A) Whole-mount images of hind paws from *Lgr5-GFP* embryos (E13.5 to E18.5). Scale bars, 1 mm.(B) Sagittal sections of the boxed areas in (A) illustrating the expression of *Lgr5* (GFP).(C) Immunostaining for GFP (green) and *in situ* hybridization for *Gdf5* (red) of adjacent sagittal sections from digit III of E14.5 hind paw, showing *Lgr5* expression is sequential to *Gdf5* in development. *Lgr5* demarcates the center of the *Gdf5-*expressing domain in P1/P2 and M/P1 interzone.(D--F) Higher magnifications of the P2/P3 joint showing *Gdf5* expression but not *Lgr5* at E14.5 (D), and its temporal expression in development (circled), as shown in the same joint at E16.5 (E) and E17.5 (F).(G) Whole-mount image of the knee from an E16.5 embryo. Scale bars, 500 μm.(H) Illustrations showing the positions and structures of the section chosen for analysis.(I and J) *Lgr5* expression during articular cartilage/meniscus (I) and cruciate ligament (J) formation from E13.5 to E18.5.M, metacarpal; P1, proximal phalange; P2, middle phalange; P3, distal phalange; F, femur; T, tibia; Ac, articular cartilage. Scale bars (B) to (F), (I), and (J) represent 100 μm.

*Lgr5* Expression Begins after *Gdf5* Expression in Digit Joint Formation {#sec2.2}
-------------------------------------------------------------------------

*Gdf5* is a marker for interzone cells ([@bib23], [@bib33]). We compared the expression of *Lgr5* with that of *Gdf5* in adjacent sections ([Figures 1](#fig1){ref-type="fig"}C--1F) in digit III. *Gdf5* is expressed in the P2/3 interzone, the last joint formed at E14.5 ([Figure 1](#fig1){ref-type="fig"}C), but not *Lgr5* ([Figure 1](#fig1){ref-type="fig"}C), indicating a later onset. Both *Gdf5* and *Lgr5* are expressed in the more proximal P1/P2 and M/P1 joints. Interestingly, *Lgr5* expression is localized to a subset of interzone cells central to the *Gdf5* expression margin of each joint ([Figure 1](#fig1){ref-type="fig"}D). At E16.5, just before cavitation, *Gdf5* expression persists in a region of the interzones in a distinct horseshoe shape ([Figure 1](#fig1){ref-type="fig"}E), with *Lgr5*^+^ cells localized to the center of the horseshoe ([Figure 1](#fig1){ref-type="fig"}F, circle) with distinct *Gdf5*^+^ flanking cells. With cavitation, the number of *Lgr5*^+^ cells decreases, whereas some *Gdf5*^+^ cells are maintained at the articular surface ([Figure 1](#fig1){ref-type="fig"}F). Thus, *Lgr5* marks a subset of *Gdf5*-expressing cells in the interzone with a distinct temporal and spatial pattern in joint development.

*Lgr5* Expression in the Developing Knee Joint {#sec2.3}
----------------------------------------------

The knee joint is more complex, with additional structures of the meniscus and cruciate ligaments. Specific *Lgr5* expression can be seen from whole-mount imaging at E16.5 ([Figure 1](#fig1){ref-type="fig"}G). We examined histological sections at the peripheral ([Figure 1](#fig1){ref-type="fig"}I) and central ([Figure 1](#fig1){ref-type="fig"}J) regions of the developing joint from E13.5 to E18.5 as indicated in [Figure 1](#fig1){ref-type="fig"}H. *Lgr5* is expressed as early as E13.5 in the interzone, before formation of the meniscus, articular cartilage, and cruciate ligaments. From E16.5, concomitant with early-stage cavitation and formation of the meniscus and cruciate ligaments, to maturation at E18.5, *Lgr5* expression becomes restricted and weaker at the future articular surfaces of the knee joint ([Figure 1](#fig1){ref-type="fig"}I, peripheral sections). However, at this stage, many *Lgr5*^+^ cells become evident in the developing lateral and medial meniscus ([Figure 1](#fig1){ref-type="fig"}I, peripheral sections). These *Lgr5*^+^ cells are localized to the "lip" or narrow regions of the meniscus. Postnatally, *Lgr5* expression diminishes with little or no detection in cells of the articular cartilage or the meniscus by day 10 (P10) ([Figure S4](#mmc1){ref-type="supplementary-material"}C). Formation of the cruciate ligaments also starts within the interzone. Strong *Lgr5* expression is detected in cruciate ligaments ([Figure 1](#fig1){ref-type="fig"}J, central sections), throughout the length of the ligaments from the base at the insertion site and into the cartilage element ([Figure 1](#fig1){ref-type="fig"}J).

*Lgr5*^+^ Interzone Cells Are Progenitors for Interior Structures of the Knee Joint {#sec2.4}
-----------------------------------------------------------------------------------

We used *Lgr5-eGFP-IRES-CreER*^*T2*^ mice to tag and trace *Lgr5*^+^ cells in the developing joints. A single injection of tamoxifen at E13.5 into *Lgr5-GFP*; *Rosa26-LacZ* (R26R) pregnant mice showed β-galactosidase-labeled (LacZ^+^) cells in the digit ([Figure 2](#fig2){ref-type="fig"}A) and knee ([Figure 2](#fig2){ref-type="fig"}B) joint interzones at E15.5. At E17.5, descendants of *Lgr5*^+^ cells persisted at cavitation ([Figure 2](#fig2){ref-type="fig"}C), and at P21 digit joints showed *Lgr5*^+^ descendants throughout the full thickness of the articular cartilage ([Figure 2](#fig2){ref-type="fig"}E). In the developing knee, descendants of *Lgr5*^+^ cells can be detected at E17.5 near the surface of the articular cartilage ([Figure 2](#fig2){ref-type="fig"}D, blue arrows), the meniscus ([Figure 2](#fig2){ref-type="fig"}D, red arrows), intrapatellar fat pad ([Figure 2](#fig2){ref-type="fig"}D, green arrows), and the developing cruciate ligaments ([Figure 2](#fig2){ref-type="fig"}D, yellow arrows). They can also be detected when traced to P21 ([Figure 2](#fig2){ref-type="fig"}F). Interestingly, many more descendants of *Lgr5*^+^ cells were detected in the ligaments than expected from the limiting labeling of interzone cells at E15.5, suggesting proliferation of cells in this lineage. Thus, *Lgr5*^+^ cells in the ligament are derived from *Lgr5*^+^ interzone cells that persisted to P21 ([Figure 2](#fig2){ref-type="fig"}F), and can be located in the synovial membrane ([Figure 2](#fig2){ref-type="fig"}F, orange arrows). Together, our findings support the notion that *Lgr5*^+^ interzone cells are progenitor cells contributing to all structures of joints.Figure 2Fate of *Lgr5*^+^ Interzone Cells in Developing Synovial JointsPregnant mice carrying *Lgr5-GFP*;*R26R* embryos were injected with tamoxifen at E13.5, and digit and knee joints of the offspring were collected at E15.5 (A and B), E17.5 (C and D), and 3 weeks postnatal (E and F) for analysis, respectively.(A and B) Cells in the interzone (IZ) are tagged as shown in embryos at E15.5 in whole mount (scale bars, 1 mm) and sagittal section stained for LacZ^+^ cells (black arrows; scale bars, 100 μm).(C--F) Descendant cells at the different stages of cell tracing at the articular surface (Ac) in both digit and knee joints (blue arrows). In the knee, LacZ^+^ cells are also detected in the meniscus (Me; red arrows), the cruciate ligaments (Cl; yellow arrows), the infrapatellar fat pad (Ifp; green arrows), and the synovial membrane (Sm; orange arrows). Scale bars, 100 μm.

*Col22a1*, a Marker in the Articular Chondrocyte Lineage {#sec2.5}
--------------------------------------------------------

To better understand *Lgr5*^+^ cells, we performed transcriptome profiling using RNA sequencing (RNA-seq). We used fluorescence-activated cell sorting (FACS) to isolate three cell types: *Sox9-*GFP^+^ cells from metacarpal cartilage anlagen of the condensed mesenchyme at E13.5 from a *Sox9*^*IRES-eGFP/+*^ (Sox9-GFP) embryo, *Lgr5*^+^ (GFP^+^) cells from developing digit joint interzones at E14.5, and *Lgr5*^−^ (GFP^−^) cells from the surrounding tissues of the interzone from *Lgr5*^*GFP/+*^ embryos ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C). With the cutoff set at fragments per kilobase of exon per million fragments mapped (FPKM) ≥5, ∼8,000 genes were identified in each pool: 7,356 were common to all three datasets; some were common to two sets, and each set contained uniquely expressed genes ([Figure S3](#mmc1){ref-type="supplementary-material"}E). The most commonly expressed genes specific to the *Lgr5*^+^ bulk dataset included transcription factors (*Glis1*, *Barx2*, and *Pknox2*) and ECM proteins (*Cilp* and *Col22a1*). Several transcription factors reported to be related to joint formation were either specifically or more strongly expressed in *Lgr5*^+^ cells from the digit joint, such as *Gata3* ([@bib31]), *Barx1/2* ([@bib22]), *Irx1/2* ([@bib35]), and *Sox5/6* ([@bib8]) ([Figure S3](#mmc1){ref-type="supplementary-material"}E and [Tables S1--S3](#mmc1){ref-type="supplementary-material"}). Known pathways regulating interzone differentiation such as WNT, TGFβ, and MAPK ([@bib4], [@bib10]) are also enriched in our *Lgr5*^+^ dataset ([Figure S3](#mmc1){ref-type="supplementary-material"}F and [Table S4](#mmc1){ref-type="supplementary-material"}). Our data agree with descriptions of interzone cells in the literature, confirming the quality of our dataset.

Next, we looked for new information and potential markers in the lineage progression to articular chondrocytes. Analysis of ECM environment of *Lgr5*^+^ cells can provide an indication of lineage progression with a change in the cell niche. *Cilp* and *Col22a1* are the top differentially expressed ECM genes in *Lgr5*^+^ cells ([Figure 3](#fig3){ref-type="fig"}A), with *Col22a1* specific to *Lgr5*^+^ cells ([Figure S3](#mmc1){ref-type="supplementary-material"}E). The overall complement of ECM genes in *Lgr5*^+^ cells indicates a chondroprogenitor phenotype not yet expressing *Comp* or *Prg4* ([Figure 3](#fig3){ref-type="fig"}A). Thus, *Cilp* and *Col22a1* are potential lineage progression markers of ECM cells. We focus on *Col22a1* (COLXXII), as it is localized to tissue junctions and detected at the superficial surface of a mature synovial joint ([@bib17]). To compare the expression of *Lgr5* and *Col22a1* during joint development, we used *in situ* hybridization for *Col22a1* ([Figures 3](#fig3){ref-type="fig"}B and 3C) and immunostaining for COLXXII ([Figures 3](#fig3){ref-type="fig"}D and 3E) and GFP (*Lgr5*) proteins from E14.5 to P0 in digit and knee joints. In E14.5 P1/P2 digit joint, *Col22a1*/COLXXII expression in the *Lgr5*^+^ interzone region was limited ([Figures 3](#fig3){ref-type="fig"}B and 3D), whereas a higher level of COLXXII was observed in the more mature M/P1 joint ([Figure 3](#fig3){ref-type="fig"}D). This indicates that the onset of *Col22a1* expression is later than *Lgr5*. Before cavitation, many cells co-express *Lgr5* and COLXXII ([Figure 3](#fig3){ref-type="fig"}D). With cavitation (E16.5), there are fewer *Lgr5*^+^ cells and more COLXXII-expressing *Lgr5*^−^ cells ([Figure 3](#fig3){ref-type="fig"}D, E16.5). Using the P1/P2 joint at E16.5 as an example, we clearly identified cells that express *Lgr5* but not *Col22a1* ([Figure 3](#fig3){ref-type="fig"}D, open arrowheads), double-positive cells ([Figure 3](#fig3){ref-type="fig"}D, solid arrowheads), and many cells expressing only COLXXII ([Figure 3](#fig3){ref-type="fig"}D, solid arrows). As COLXXII is an ECM protein, we define double-positive cells as cells that are GFP^+^ (intracellular) with pericellular staining for COLXXII. This is supported by direct co-localization of *Col22a1* mRNA in *Lgr5*-expressing cells ([Figure 3](#fig3){ref-type="fig"}B). By E18.5, there were only a few *Lgr5*^+^ cells, which are likely to be double positive for COLXXII as they are embedded in a COLXXII-enriched ECM layer ([Figure S4](#mmc1){ref-type="supplementary-material"}A). At this stage, COLXXII-expressing cells marked the surface of the future articular cartilage. By birth (P0), a distinct thin layer of COLXXII-containing ECM became apparent, and the proximal/distal expression difference was no longer evident ([Figure S4](#mmc1){ref-type="supplementary-material"}B). Similarly, at P10 ([Figure S4](#mmc1){ref-type="supplementary-material"}C), *Lgr5*^+^ cells were no longer detectable along the entire surface of the digit joint.Figure 3Dynamic Spatiotemporal Expression of Lgr5 and Collagen XXII in Knee Joint Development(A) Matrix genes with higher expression in *Lgr5*^+^ compared with *Lgr5-*from digit bulk transcriptome. "+∞" indicates that a gene is not expressed in the *Lgr5*^−^ cell population. Genes with asterisks indicate that expression data for the developing joint are available in Eurexpress.(B and C) Co-expression of *Lgr5* (GFP) and *Col22a1* mRNA in digit (B; scale bars, 50 μm) and knee joints (C; scale bars, 100 μm); boxed areas are shown in the bottom panels. Cells positive to Lgr5-GFP only are indicated with open white arrowheads, double positive to Lgr5-GFP/*Col22a1* with solid white arrowheads, and cells expressing only *Col22a1* with solid arrows.(D) Double fluorescent immunostaining of *Lgr5-GFP* (green) and COLXXII (red) on sagittal sections of the developing knees of *Lgr5-GFP* embryos at E14.5 and E18.5 (see also [Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). Images of the boxed areas are shown on the right panels. Formation of the articular cartilage progresses from Lgr5^+^ cells (open white arrowheads), to cells expressing both Lgr5 and COLXXII (solid white arrowheads), to cells expressing only COLXXII (solid arrows). Scale bars, 200 μm.(E) Co-localization of *Lgr5* and COLXXII in developing articular cartilage and meniscus. COLXXII matrix layer condenses to a very narrow region at the superficial surface of the fully developed articular cartilage and meniscus. Boxed regions are shown in the right panels. Scale bars, 200 μm.(F) LacZ^+^ descendant cells of Lgr5 (arrows), with tamoxifen (TM) injected at E13.5 and harvested at E17.5 can be detected at the COLXXII^+^ superficial layer (brackets) of the articular cartilage and meniscus. Scale bars, 100 μm.(G--I) All cells in this layer (G; brackets) express *Col22a1* in a comparable section. Co-localization of COLXXII with Lgr5 (GFP) (H) and *Scx* (GFP) (I). Histology of the same sections stained with Alcian blue and nuclear fast red (H and I, lower panels). F, femur; T, tibia; Cl, cruciate ligament. Scale bars, 50 μm.See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}.

In the knee, a similar expression relationship is observed ([Figures 3](#fig3){ref-type="fig"}C and 3E). *Lgr5* is expressed at E13.5 ([Figure 3](#fig3){ref-type="fig"}E) and E14.5 ([Figures 3](#fig3){ref-type="fig"}C and 3E) as the interzone cells condense to form the articular cartilage and meniscus. *Lgr5*^+^ cells first mark the structure of the future meniscus at E13.5, followed by the condensation of COLXXII-expressing cells along the superficial layer from E15.5 to E18.5 ([Figure 3](#fig3){ref-type="fig"}E). Differentiation to superficial meniscus cells is also likely to involve a transition from *Lgr5-* to COLXXII-expressing cells. Indeed, *Lgr5*/COLXXII double-positive cells were detected at the boundary by immunostaining at E15.5 ([Figure 3](#fig3){ref-type="fig"}E) and by *in situ* hybridization at E17.5 ([Figure 3](#fig3){ref-type="fig"}C). By E18.5 ([Figures 3](#fig3){ref-type="fig"}C and 3E), a distinct layer of COLXXII-containing matrix was present, with some *Lgr5*^+^ cells in the deeper region of the meniscus. Similar to digit joints, *Lgr5*^+^ cells were no longer detectable at P10, but the COLXXII layer persisted ([Figure S4](#mmc1){ref-type="supplementary-material"}C). At E17.5, we detected *Lgr5*-descendant cells (LacZ^+^) labeled on E13.5 in the COLXXII-containing superficial layer ([Figure 3](#fig3){ref-type="fig"}F) where *Col22a1* transcripts were also detected ([Figure 3](#fig3){ref-type="fig"}G), indicating that some of the cells in this layer come from *Lgr5*^+^ interzone cells. Furthermore, cells embedded in this layer interact with the ECM as indicated by the clustering of β1-integrin into focal adhesions ([Figure S4](#mmc1){ref-type="supplementary-material"}D).

Because *Lgr5* is also expressed in the developing ligaments, we analyzed its expression/localization relationship with COLXXII at E15.5, when the cruciate ligaments start to form ([Figures 3](#fig3){ref-type="fig"}H and 3I). Interestingly, while *Lgr5*^+^ cells are detected throughout the central region of the interzone, COLXXII expression is localized to the flanking regions outside of the developing ligaments ([Figure 3](#fig3){ref-type="fig"}H). Furthermore, analysis of COLXXII expression in a *Scx*-GFP mouse showed distinct expression of *Scx* (GFP) restricted within the developing ligament and not in the flanking COLXXII-positive regions of the interzone ([Figure 3](#fig3){ref-type="fig"}I). This supports lineage divergence of *Lgr5*^+^ progenitors to ligament cells and articular chondrocytes, with mutually exclusive expression patterns, and that there is a distinct ECM niche for these two lineages. A COLXXII-containing niche would support the formation of articular cartilage and meniscus.

Distinct Signatures of *Lgr5*^+^ Interzone Cells for Chondrocyte or Ligament Lineages {#sec2.6}
-------------------------------------------------------------------------------------

To investigate the relationships of different cell populations in the developing knee joint, we performed single-cell RNA-seq analysis of cells from knee interzone regions of *Lgr5*^*GFP/+*^ embryos at E14.5. After exclusion of blood cells, 5,460 interzone and surrounding cells were sequenced ([Table S5](#mmc1){ref-type="supplementary-material"}). T-distributed stochastic neighbor embedding (tSNE) analysis grouped cells with similar expression profiles into six clusters. When the tSNE map was viewed in two dimensions (2D-tSNE), clusters 4 and 5 appeared to be distant from the main clusters (1, 2, 3, 6) ([Figure 4](#fig4){ref-type="fig"}A). The 3D view (3D-tSNE) showed a horseshoe shape, with clusters 1 and 5 at the tips of the horseshoe ([Figure 4](#fig4){ref-type="fig"}B). *Gdf5*, a marker for all interzone cells, is expressed in cells scattered throughout the six clusters ([Figure 4](#fig4){ref-type="fig"}C), but appeared concentrated within clusters 1, 2, 5, and 6 ([Figure 4](#fig4){ref-type="fig"}E). A total of 207 *Lgr5*-expressing cells were identified among cells expressing the endogenous *Lgr5* (n = 94), the *Lgr5-eGFP-CreER*^*T2*^ allele (n = 87), or both (n = 26). Interestingly, *Lgr5* expression is concentrated in clusters 1 (64% of all *Lgr5*^+^ cells) and 5 (13%) at the tips of the horseshoe ([Figure 4](#fig4){ref-type="fig"}D), and is well illustrated in the 2D-tSNE heatmap ([Figure 4](#fig4){ref-type="fig"}F). Other *Lgr5*^+^ cells are scattered throughout the cluster map ([Figure 4](#fig4){ref-type="fig"}D).Figure 4Properties and Molecular Signatures of *Lgr5*^+^ Cells in E14.5 Knee Joint Interzone Revealed by Single-Cell Transcriptome(A and B) Gene expression from 5,460 cells was analyzed using tSNE plots in 2D (A) or 3D (B), with six major clusters identified.(C and D) 3D view for the distribution of *Gdf5*^+^ (C) and *Lgr5*^+^ (D) cells. The relative distribution of *Lgr5* expression in the different clusters is presented as a pie chart in (D).(E and F) Contour plots illustrating the density of cells expressing (F) *Lgr5* shown in (B), and (E) *Gdf5* shown in (C), with the corresponding colored density chart.(G) 2D-tSNE showing the distribution of *Lgr5*^+^ among *Gdf5*^+^ cells. Higher magnification of the boxed area in cluster 1 is shown on the right panel, highlighting the relative *Lgr5*^+^*/Gdf5*^−^ (cyan) and *Lgr5*^+^*/Gdf5*^+^ (purple) cells.(H) Venn diagram illustrating the distribution and percentages of *Lgr5*^−^*/Gdf5*^+^ (green), *Lgr5*^+^/*Gdf5*^−^ (cyan), and *Lgr5*^+^*/Gdf5*^+^ (purple) subpopulation of cells.(I) 2D-tSNE plot highlighting the distribution of *Lgr5*^+^*/Ki67*^+^ in cluster 5, relative to the dominance of *Lgr5*^+^*/Ki67*^−^ cells in cluster 1, and the percentage of *Lgr5*^+^*/Ki67*^+^ shown in a pie chart.(J) Double immunofluorescence detection of Lgr5-GFP- and Ki67-expressing cells in an E14.5 knee joint. The peripheral of the Lgr5 cell population is marked with a dotted line, and arrows indicate the double-positive cells with the boxed region shown in higher magnification. The relative percentage of Lgr5^+^/Ki67^+^, determined from three embryos, is also shown in a pie chart. F, femur; T, tibia. Scale bars, 20 μm.(K) Venn diagram showing the DEGs of cluster 1 versus non-cluster 1 (n = 110, blue circle) and DEGs *Lgr5*^+^ versus *Lgr5*^−^ cells (n = 75, yellow circle). There are 48 common DEGs identified with these two gene lists. Transcription factors in each sector are shown.See also [Figure S5](#mmc1){ref-type="supplementary-material"} and [Table S6](#mmc1){ref-type="supplementary-material"}.

Next, we assessed the relationship between *Lgr5*^+^ and *Gdf5*^+^ cells. We expected *Lgr5*^+^ cells to be *Gdf5*^+^ from our *in vivo* analysis at E14.5 ([Figures 1](#fig1){ref-type="fig"}C and 1D). We observed *Gdf5*^+^/*Lgr5*^−^ and *Gdf5*^+^/*Lgr5*^+^ cells, but also *Gdf5*^−^/*Lgr5*^+^ cells ([Figures 4](#fig4){ref-type="fig"}G and 4H). Differentially expressed gene (DEG) analysis of *Lgr5*^+^/*Gdf5*^−^ and *Lgr5*^+^/*Gdf5*^+^ cells found the only difference was the absence or presence of *Gdf5* expression ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Thus, these two cell populations are the same, and the difference is likely due to a "dropout" event in single-cell RNA-seq ([@bib15]) for *Gdf5* if its expression was low in some *Lgr5*^+^ cells. Similar DEG analysis of clusters 1 and 5 of *Lgr5*^+^ cells showed that the key difference was additionally expressed genes in cluster 5 that mapped to Gene Ontology terms corresponding to cell-cycle events ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C). We selected *Ki67* as one of the most differentially expressed cell-cycle genes and mapped its expression in the 2D-tSNE profiles. A total of 14% of the *Lgr*5^+^ cells in all clusters expressed *Ki67*; most of them are in cluster 5 but not in cluster 1 ([Figure 4](#fig4){ref-type="fig"}I). Similarly, we found that 12.2% ± 2.1% (n = 3) of *Lgr5*^+^ cells in the E14.5 knee interzone region expressed Ki67; these cells were located around the periphery of the *Lgr5*^+^ interzone region ([Figure 4](#fig4){ref-type="fig"}J).

As most *Lgr5*^+^ cells were in cluster 1, we conducted a DEG analysis of cluster 1 against the other five clusters. We identified 110 DEGs ([Figure 4](#fig4){ref-type="fig"}K and [Table S6](#mmc1){ref-type="supplementary-material"}), including transcription factors related to joint development such as *Osr2*, *Trps1*, *Barx1*, and *Sox4*. When we increased the stringency by comparing *Lgr5*^+^ cells in cluster 1 with *Lgr5*^−^ cells in the whole population, we identified 75 DEGs ([Table S6](#mmc1){ref-type="supplementary-material"}), 48 of which overlapped with the previous gene set including the transcription factors *Mkx* and *Scx*. Twenty-seven genes were specifically expressed in *Lgr5*^+^ cells, including the transcription factor *Meox2* ([Figure 4](#fig4){ref-type="fig"}K). Together, these analyses described distinct signatures of *Lgr5*^+^ cells in the interzone for the chondrocyte and ligament lineages.

Trajectories of Joint Lineage Specification {#sec2.7}
-------------------------------------------

To annotate these clusters, we clustered the top 5% of the dispersed genes (genome-wide of all 5,460 cells) into a heatmap. Gene modules associated with interzone, ligament, cell cycle, and cartilage were identified ([Figure 5](#fig5){ref-type="fig"}A). As expected from the 2D-tSNE heatmap for *Gdf5* expression ([Figure 4](#fig4){ref-type="fig"}E), cells in clusters 1, 2, 5, and 6 expressed genes associated with interzone cells, including *Gdf5*, *Osr2*, *Sfrp2*, *Sulf1*, and *Sox4*. Relative to other clusters, cells in clusters 5 and 6 expressed higher levels of genes related to ligament, such as *Lox*, *Col1a1*, *Aspn*, and *Scx*. The major difference between cluster 5 and cluster 6 was the high abundance of cell-cycle-related genes in cluster 5, such as *Ki67*, *Ccna2*, *Birc5*, and *Top2a*, which are also expressed in cluster 4. Cells in clusters 2, 3, and 4 expressed cartilage-related genes such as *Epyc*, *Matn1*, *Acan*, *Lect1*, and *Sox9*. When we analyzed the same dataset with principal component analysis, we found similar clustering of interzone and non-interzone cells as well as similar cell-cycle status of cells in these clusters ([Figures S5](#mmc1){ref-type="supplementary-material"}D--S5G). The expression profile in each of the clusters agreed with the violin plots of representative genes for cartilage and ligament, and cell-cycle genes ([Figure S5](#mmc1){ref-type="supplementary-material"}H). Thus, clusters 1, 2, 5, and 6 are considered "interzone clusters," whereas 3 and 4 are defined as "non-interzone clusters" ([Figure 5](#fig5){ref-type="fig"}B). Cluster 1 is enriched with *Lgr5*^+^/*Gdf5*^+^ interzone cells and is mapped between the clusters with the ligament (cluster 6) and chondrocyte (cluster 2) signatures, with some "mixing" of cells at the borders, implicating a potential divergence of the cluster 1 interzone cells into either chondrocytes or ligament lineages ([Figure 5](#fig5){ref-type="fig"}B).Figure 5Lineage Trajectories of Knee Joint(A) Heatmap showing the clustering of the top 5% dispersed genes (genome-wide), from the profiles of 200 cells randomly selected from each cluster as a representative. Gene clusters related to joint development, ligament, cell cycle, and cartilage were identified.(B) Summary diagram of the property/signature of each cluster, with clusters 1, 2, 5, and 6 defined as interzone cells.(C) Pseudo-timeline analysis of cells from clusters 1, 2, 5, and 6 identified eight cell states, and the distribution of cells from individual cluster and a combined map along the pseudo-timeline is shown.(D) Distribution of all *Lgr5*^+^ cells along the pseudo-timeline, and relative percentages distributed in each of the cell state indicated, together with proliferative *Lgr5*^+^*/Ki67*^+^ cells.(E--G) The pseudo-timeline (E) predicted a gradient of "early" (dark blue) to late (light blue) cells, with a major divergence to two trajectories A and B, with arrows indicating the predicted direction. Expression distribution of ligament (F) and chondrocyte (G) genes are mapped onto the 2D tSNE. The size of each circle is a relative reflection of the gene expression level; *Lgr5*^+^ cells are indicated as green.(H) Illustration showing the major lineage divergence of *Lgr5^+^* interzone cells.(I and J) Distribution of cells expressing ligament (I) and cartilage (J) genes along the pseudo-timeline. The boxes highlight a specific comparison of cells in state II expressing a mature ligament marker *Tnmd* but not *Col22a1*.

To study the cell-lineage divergence, we performed a pseudo-timeline analysis focusing on the interzone clusters (1, 2, 5, and 6) that mapped into eight potential cell states ([Figure 5](#fig5){ref-type="fig"}C). Cells in cluster 1 mapped mainly in state I with some cells scattered throughout other states. Cells in clusters 5 and 6 with the ligament signature were distributed in states I, II, and III, while cells in cluster 2 with the chondrocyte signature were distributed primarily in cell states V, VI, VII, and VIII ([Figure 5](#fig5){ref-type="fig"}C). State IV contained a mixture of cells from all four clusters. Next, we assessed the distribution of *Lgr5*^+^*/Ki76*^+^ cells and showed that they are distributed within *Lgr5*^+^*/Ki67*^−^ cells, but most *Lgr5*^+^ cells mapped to state I ([Figure 5](#fig5){ref-type="fig"}D), which represents the most primitive/young state as predicted in the pseudo-timeline ([Figure 5](#fig5){ref-type="fig"}E). Two major trajectories branched from state I: trajectory A consisted of cells in states II/III ([Figure 5](#fig5){ref-type="fig"}E, green arrows) and trajectory B included cells in states V/VI/VII/VIII ([Figure 5](#fig5){ref-type="fig"}E, red arrows).

To characterize the trajectories, we assessed expression of the differentially expressed transcription factors identified ([Figure 4](#fig4){ref-type="fig"}K). *Scx*, *Meox2*, and *Mkx* are expressed in ligament cells, and their expression is enriched in cells of clusters 1 and 6 ([Figure 5](#fig5){ref-type="fig"}F, green oval) but less in cells of cluster 2 ([Figure 5](#fig5){ref-type="fig"}F, pink oval). *Osr2* and *Barx1* are expressed in cartilage development and their expression is enriched in clusters 1 and 2, but less in cluster 6 ([Figure 5](#fig5){ref-type="fig"}G). *Sox9*, a key chondrogenic transcription factor, is not differentially expressed in cluster 1 or among *Lgr5*^+^ cells: overall, its expression is upregulated in cluster 2 but not in cluster 6 ([Figure 5](#fig5){ref-type="fig"}G). This supports a divergence of cells in cluster 1 from a "bipotential" state that can differentiate along the ligament or the articular cartilage lineage ([Figure 5](#fig5){ref-type="fig"}H). Next, we mapped the transcription factors and ECM genes specific to ligament ([Figure 5](#fig5){ref-type="fig"}I) and cartilage ([Figure 5](#fig5){ref-type="fig"}J) onto the pseudo-timeline and found them to be enriched in the cell states that supported the relevant tissue trajectory ([Figure 5](#fig5){ref-type="fig"}E). Based on the algorithm for the trajectory, some cells co-expressed both ligament and cartilage transcription factors prior to the lineage divergence. For example, cells from cluster 6 distributed at the end of state I expressed both *Meox2* (blue circles in [Figure 5](#fig5){ref-type="fig"}I, left panel) and *Osr2* (blue circles in [Figure 5](#fig5){ref-type="fig"}J, left panel). In support of the *in vivo* data ([Figure 3](#fig3){ref-type="fig"}H), state II cells in trajectory A did not express *Col22a1* but did express the mature ligament marker *Tnmd* ([Figures 5](#fig5){ref-type="fig"}I and 5J, blue boxes). *Col22a1* was expressed in cells of trajectory B, supporting our hypothesis that *Col22a1* marks the chondrocyte lineage as distinct from the ligament lineage. Thus, our single-cell transcriptome data, together with our lineage-tracing experiment, showed *Lgr5*^+^ interzone cells are likely to be multipotent and represent a stage of joint formation at which the lineage divides into ligament and articular chondrocytes ([Figure 5](#fig5){ref-type="fig"}H).

*Lgr5*^+^ Interzone Tissue Repairs Cartilage Lesion {#sec2.8}
---------------------------------------------------

*Lgr5*^+^ interzone cells could be suitable for the repair of cartilage, as they are "primitive" and multipotent. To test this capacity, we dissected the *Lgr5-GFP*^+^ interzone tissue from E13.5 *Lgr5-GFP;ROSA-tdTomato* embryos and transplanted it to a full-thickness needle-puncture lesion at the trochlear groove of the knee of 8-week-old mice (n = 3) ([Figures 6](#fig6){ref-type="fig"}A and [S6](#mmc1){ref-type="supplementary-material"}B). Fifteen days post puncture, tdTomato^+^ cells were detected in the lesion, as differentiating round chondrocytes in the intermediate and deep zones of articular cartilage ([Figures 6](#fig6){ref-type="fig"}B and 6C, arrows; control section is shown in [Figure S6](#mmc1){ref-type="supplementary-material"}A) and flattened cells in the superficial zone ([Figures 6](#fig6){ref-type="fig"}B and 6C, arrowheads). The healing lesion contained cells that originated from the transplanted tissue, which produced proteoglycan-enriched matrix ([Figure 6](#fig6){ref-type="fig"}C) and COL II deposition ([Figure 6](#fig6){ref-type="fig"}D). The new tissue integrated well with the host cartilage ([Figure 6](#fig6){ref-type="fig"}C, box) with a new superficial layer containing COLXXII and CILP1 intercalated with the superficial zone of the host articular cartilage ([Figures 6](#fig6){ref-type="fig"}E and 6F). The implanted tissue suppressed expression of COL I ([Figure 6](#fig6){ref-type="fig"}G) in the lesion, which could result in unwanted fibrosis during cartilage repair. Together, our findings suggest that *Lgr5*^+^ interzone cells have repair capacity for articular cartilage.Figure 6Capability of *Lgr5*^+^ Interzone Tissue to Repair Cartilage Lesion(A) Experimental design for the isolation of *Lgr5*^+^ interzone tissue (labeled with both GFP and tdTomato) and transplantation into articular cartilage defect for repair. The right panel shows the tdTomato^+^ tissue inside the lesion directly after transplantation. Scale bars, 1 mm.(B) Implanted interzone tissue (tdTomato^+^) integrated with the host cartilage and differentiated into cells in articular cartilage and flattened cells in the superficial layer (arrowheads), 15 days post implantation.(C--G) Histological (C) and ECM marker (D--G) analyses performed on lesion with and without *Lgr5*^+^ implantation after 15 days. High magnifications of the boxed areas are shown in the insets.Scale bars, 50 μm. See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

Discussion {#sec3}
==========

The diverse tissues of the synovial joint derive from mesenchymal cells in the developing interzone, most or all of which express *Gdf5* ([@bib18]). Tracing studies in a *Gdf5-CreER*^*T2*^ mouse showed that after the initial dedifferentiation of chondrogenic cells to *Gdf5*^+^ interzone cells, further expansion of the *Gdf5*^+^ region is primarily through recruitment of regional mesenchymal cells rather than proliferation of *Gdf5*^+^ interzone cells ([@bib30]). Furthermore, [@bib30] proposed that cells within the interzone have contextual cues, and their ability to produce distinct joint tissues is governed by positional effects. Here, we identified a new subset of *Gdf5*-expressing interzone cells, distinguished by co-expression of *Lgr5*, a known marker for highly proliferative stem cells ([@bib20]), although cell division is rare within the interzone ([@bib30]). Significantly, this subset of *Lgr5*-expressing cells in the *Gdf5*^+^ population can also give rise to the diverse tissues of the joint, including the synovial membrane, cruciate ligaments, meniscus, and articular cartilage.

*Lgr5*^+^ Interzone Cells Contribute to the Making of the Diverse Joint Structures {#sec3.1}
----------------------------------------------------------------------------------

The *Lgr5*^+^ cell pool emerges shortly after the initial appearance of *Gdf5*-expressing cells marking the future joint site. Therefore, *Lgr5*^+^ cells are likely to be derived from *Gdf5*^+^ cells that have undergone dedifferentiation, consistent with cell-fate mapping findings using *Gdf5-*Cre mice ([@bib18]), and that the progressive differentiation from a *Gdf5*^+^ to a *Lgr5*^+^ cell is a sequential event. In the digit joints, because *Lgr5*^+^ cells arise and remain localized within the center of the interzone, incoming *Gdf5*^+^ cells proposed in the continuous influx model ([@bib30]) would be the peripheral to the central pool of *Lgr5*^+^ cells. Our single-cell transcriptome showed that the *Lgr5*^+^ pool expands in part through differentiation and proliferation of the peripheral interzone cells, shown by the presence of *Lgr5*^+^/*Ki67*^+^ cells in the developing joint, and a population of *Lgr5*^+^ cells that differ only in the expression of active cell-cycle-related genes in the tSNE map of cell clusters. Other mechanisms might exist in the more complex knee interzone.

In our mapping study, activation of the *LacZ* at E13.5 would tag this early pool of *Lgr5*^+^ cells, and we observed that they can contribute to all structures of the joint. Having only a few *Lgr5*-expressing cells tagged from a single tamoxifen injection allows us to assess the level of contribution to the different structures of the joint. In the developing knee joint, there were no observable differences in the contribution of *Lgr5*^+^ cells to the articular cartilage, meniscus, and synovium. Interestingly, many more descendant cells are found in the cruciate ligaments, suggesting that they have proliferated. Furthermore, *Lgr5* continues to be expressed in cells of the developing ligament, consistent with expansion of the tagged *Lgr5*^+^ cells from the E13.5 interzone with numerous descendant cells in the ligament at E17.5. This is supported by the identification of a ligament cell cluster with active cell-cycle genes in the tSNE map of the single-cell transcriptome data from an E14.5 interzone.

*Lgr5*^+^ Cells Are Poised Progenitors at the Onset of Lineage Divergence {#sec3.2}
-------------------------------------------------------------------------

Consistent with the *in vivo* analyses, the transcriptomic data from both the bulk and single-cell analyses support *Lgr5*^+^ cells as progenitors "poised" for differentiation along the articular chondrocyte or ligament lineages. Using the clusters representing the interzone cells to derive a pseudo-timeline, we identified eight cell states, placing cluster 1 with the bulk of the *Lgr5*^+^ cells as the most "primitive" state I of "poised" progenitor cells ([Figure 5](#fig5){ref-type="fig"}D). Many *Lgr5*^+^ cells in state I express gene signatures for both ligament and chondrocyte, then specialize into the more distinct signature for the ligament or chondrocyte lineages. Changes in the balance of lineage-specifying transcription factors may control the divergence.

Interestingly, about 10% of *Lgr5*^+^ cells are found in state V, predicted to be derived from state I, and the reason for this is unclear. It is possible that these are from cells recruited differently in joint development ([@bib30]), and this cannot be excluded. Multiple cell states exist within each of the ligament or chondrocyte trajectories, suggesting that there are subclasses of cells within each lineage, possibly related to their position along the cruciate ligament, or differences between chondrocytes residing in the articular or meniscus regions. For example, a multipotent *Scx*^+^/*Sox9*^+^ progenitor cell pool at the chondro-tendinous/ligamentous junction gives rise to tenocytes/ligamentocytes and chondrocytes ([@bib34]). We propose that there could be positional values for these cells within the developing knee joint, as depicted in a model based on our current findings ([Figure 7](#fig7){ref-type="fig"}).Figure 7Model for the Contribution and Divergence of Progenitor Cells in Joint FormationA schematic diagram showing the developmental processes of a knee joint.(A) Formation of the cartilage anlagen containing *Sox9*-expressing chondrocytes.(B) Dedifferentiation of *Sox9*^+^ chondrocytes to *Gdf5*^+^ interzone cells at the presumptive joint site.(C) Expansion of the interzone through recruitment of mesenchymal cells from the surrounding and limited proliferation of peripheral *Lgr5*^+^ cells, and the partitioning of the interzone into specific regions.(D) *Lgr5*^+^ interzone cells undergo lineage divergent and differentiate into cells for the different tissues in a mature joint.(E) *Lgr5*^+^ interzone cells are multipotent progenitors contributing to all interior structures of the knee joint including cruciate ligaments, articular cartilage, and menisci. *Lgr5*^+^/*Scx*^−^/*Col22a1*^+^ cells are committed progenitors for articular chondrocyte lineage and menisci, whereas *Lgr5*^+^/*Scx*^+^/*Col22a1*^−^ cells are restricted within the ligament lineage.

Role of Lgr5 and Wnt Signaling in Joint Development {#sec3.3}
---------------------------------------------------

Although Lgr5-GFP homozygous mice are perinatal lethal ([@bib1]), they show no histological abnormality in joints ([Figure S2](#mmc1){ref-type="supplementary-material"}). This might be due to functional redundancy among the three LGR proteins (*LGR4, LGR5*, and *LGR6*) ([@bib28]). *Lgr4* is expressed in our transcriptome dataset, although *Lgr6* is not. *Lgr5* expression may reflect a positional effect at an appropriate level of Wnt ligands for its activation, and the potentiation of Wnt signaling by *Lgr5* in turn sustains a higher signaling level through interaction with R-spondins ([@bib3]), necessary for the progression to the next stage, poised for the formation of other structures and cavitation.

Col22a1 Marks an Articular Cartilage Lineage from Lgr5-Expressing Interzone Cells {#sec3.4}
---------------------------------------------------------------------------------

Decreasing *Lgr5* expression with cavitation and in cells at the juvenile articular surface is consistent with the need to reduce anti-chondrogenic Wnt signal for articular chondrocyte differentiation. We know very little about the molecular control of this lineage. Chondrogenic bone morphogenetic protein signaling plays an important role ([@bib27]), supported by the continuing expression of *Gdf5* while *Lgr5* decreases, tipping the balance to chondrogenesis, and our identification of *Col22a1* as an intermediate marker for this lineage and cells co-expressing *Col22a1* and *Lgr5*. *Col22a1*/COLXXII expression started proximally, but then occurred close to the margins of the future articular surface within the developing interzone. This is best illustrated in the less complex digit joints, and is consistent with the proposed model whereby the developing interzone is organized into three layers, with the two outer layers containing cells committed to become articular chondrocytes, and cells in the middle layer contributing to other structures or undergoing apoptosis ([@bib24]). The COLXXII-expressing cell layers within the interzone are broad just prior to cavitation. Overlap between the COLXXII-expressing regions and *Lgr5*^+^ cells at the earliest stage of cavitation suggests that most *Col22a1*-expressing cells are derived from *Lgr5*^+^ cells. Interestingly, the *Lgr5*^+^/*Col22a1*^+^ co-expressing cells are primarily localized to the mid region of the articular surface throughout the cavitation process, with *Col22a1*^+^/*Lgr5*^−^ cells occupying the flanking regions along the entire surface of the joint. If *Col22a1-*expressing cells are derived from *Lgr5*^+^ cells, expansion of the articular surface is mediated through cellular differentiation at the midpoint contributing to the lateral growth of the joint surface. Indeed, this may have been reflected in the multiple cell states identified in the chondrocyte trajectory from the pseudo-timeline prediction of the single-cell transcriptome ([Figures 5](#fig5){ref-type="fig"}D and 5E).

We propose a model whereby cells express *Gdf5*, progress to *Gdf5^+^*/*Lgr5^+^* double-positive progenitor cells, then *Lgr5^+^*/*Col22a1^+^* double-positive committed articular chondrocyte progenitors, and finally *Col22a1*-expressing juvenile articular chondrocytes ([Figure 7](#fig7){ref-type="fig"}). The continuous influx model invokes an expansion of the *Gdf5*^+^ interzone cell pool from recruitment ([@bib30]). We propose that a spatial effect of the various pools of committed progenitors dictates the positioning of the joint structures. Single-cell transcriptome with more cells from additional developmental time points should provide key markers for validation, and further insights into the molecular controls and subdivision of cell states.

Capacity of *Lgr5*^+^ Cells in Cartilage Repair: Re-establishment of the Collagen XXII-Containing Superficial Layer {#sec3.5}
-------------------------------------------------------------------------------------------------------------------

The superficial zone contains cells producing Lubricin/*Prg4* for joint lubrication ([@bib19]) and progenitor cells ([@bib7]). Recent cell-tracing studies identified self-renewing progenitor cells at the superficial zone of the mouse articular cartilage that may undergo symmetric and asymmetric expansion in juvenile joints ([@bib5], [@bib21]). Our analysis showed that COLXXII demarcates the outermost surface of the joint. Cells embedded in the COLXXII-containing layer have a distinct flattened morphology with direct interaction with the ECM, shown by the presence of focal adhesions with clustering of β1-integrin receptors. These cells might provide a special niche for cell maintenance and act as a source of progenitors. Finally, we showed that *Lgr5*^+^ cells collected from an E13.5 embryonic knee joint can repair a full-thickness articular cartilage defect. Importantly, a COLXXII-containing superficial layer was re-established in the healing defect, which quickly integrated with the host cartilage, indicating that these *Lgr5*^+^ cells are candidates for cell-based therapy for cartilage and ligament trauma or associated degenerative diseases.

Experimental Procedures {#sec4}
=======================

Mouse Strains {#sec4.1}
-------------

*Lgr5-eGFP-IRES-CreER*^*T2*^ (Lgr5-GFP) ([@bib1]), *ROSA26-LacZ* (R26R) reporter ([@bib32]), and *Scx-GFP* ([@bib26]) mice were maintained in C57bl/6 background. PCR primers for genotyping these mice are listed in [Table S7](#mmc1){ref-type="supplementary-material"}. All animal works were approved by the Committee on the Use of Live Animals in Teaching and Research of the University of Hong Kong.

Real-Time qPCR {#sec4.2}
--------------

mRNA was extracted from E14.5 digit interzone and surrounding non-interzone regions using TRIzol reagent (Thermo Fisher). cDNA was generated using the PrimeScript RT reagent kit (Clontech). qPCR was performed using LightCycler480 SYBR Green I Master kit (Roche). All primers are listed in [Table S7](#mmc1){ref-type="supplementary-material"}.

*In Situ* Hybridization and Immunohistochemistry {#sec4.3}
------------------------------------------------

*In situ* hybridization was performed as previously described ([@bib9]), using \[α-^35^S\]uridine triphosphate-labeled riboprobes for *Gdf5*. Fluorescence *in situ* hybridization was performed as previously described ([@bib29]), using a digoxigenin-labeled probe for *Col22a1*. For immunohistochemistry, sections were incubated with primary antibodies for goat anti-GFP (ab6673), guinea pig anti-COLXXII (produced by Dr. Manuel Koch), sheep anti-CILP1 (R&D Systems), and rabbit anti-Ki67 (Abcam ab1558), and detected using the relevant secondary antibodies (Alexa Fluor 488 anti-rabbit \[Thermo Fisher\], Alexa Fluor 488 anti-goat \[Abcam\], Alexa Fluor 488 anti-sheep \[Abcam\], and Cy3 anti-guinea pig immunoglobulin G \[Jackson ImmunoResearch\]).

Lineage Tracing and X-gal Staining {#sec4.4}
----------------------------------

Tamoxifen (Sigma) was administered by intraperitoneal injection (0.2 mg/g body weight) to pregnant mice carrying Lgr5-GFP/R26R embryos at E13.5. Limbs were processed for whole-mount X-gal staining to detect LacZ activity. Three-week-old samples were decalcified overnight in 0.5 M EDTA (pH 7.5); 7-μm paraffin sections were counterstained with eosin.

Imaging {#sec4.5}
-------

Images were acquired using an Axioplan 2 microscope (Zeiss) with SPOT-camera or the Leica TCS SPE Live confocal microscope. The contrast and color of some images were adjusted with the "brightness/contrast" and "hue/saturation" functions in Adobe Photoshop CS. No further modifications of the images were made.

Bulk Transcriptome Analysis {#sec4.6}
---------------------------

*Sox9*^+^ cells were isolated from digits of E13.5 *Sox9-GFP* embryos ([@bib25]). *Lgr5*^+^ and surrounding non-*Lgr5* (*Lgr5*^−^) cells were isolated from forelimb digit interzones of E14.5 *Lgr5*^*GFP/*+^ mice ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C). Cells were released with a mixture of TrypLE Express (Gibco) and 0.1% DNase I for 20 min, filtered through a 40 μm cell strainer, and sorted by FACS using an Aria I flow cytometer (BD Biosciences). Total RNA was extracted using a mirVana miRNA Isolation Kit (Ambion) and cDNA libraries were constructed with 10 ng of RNA using a SMARTer Ultra Low Input Kit (v3, Illumina), and sequenced using the Illumina HiSeq 1500 platform (Center for Genomic Sciences, The University of Hong Kong). cDNA fragment sequences were aligned to mouse genome (mm10) using the HISAT program ([@bib16]). FPKM values were generated for comparison ([Figure S3](#mmc1){ref-type="supplementary-material"}D). Genes with FPKM ≥ 5 were considered as expressing genes. Pathway and expression analyses were performed with DAVID ([@bib13]) and Eurexpress ([@bib6]) databases, respectively. Datasets have been uploaded to the Gene Expression Omnibus for public access (GEO: [GSE110281](ncbi-geo:GSE110281){#intref0010}).

Single-Cell Transcriptome Analysis {#sec4.7}
----------------------------------

The knee interzone and surrounding cartilage tissues were dissected with the aid of GFP expression from E14.5 *Lgr5*^*GFP/*+^ embryos. Dissociated cells were pooled for single-cell RNA sequencing with 10X Genomics Chromium Single Cell Controller for encapsulations (10X Genomics). cDNA libraries were prepared according to the manufacturer\'s instructions (Chromium Single Cell 3′ Reagent Kits v2 and Chromium Single Cell A Chip Kit), then sequenced on the Illumina HiSeq 1500 platform. The raw data were processed with the Cell-Ranger pipeline (version 2.1.0; 10X Genomics) for alignment to mm10, quantification of UMIs (unique molecular identifiers), and dimension-reduction (tSNE) analysis. Data were aligned to CreER^T2^ sequence to assess the expression of the *Lgr5-eGFP-CreER*^*T2*^ allele. Cells expressing *Lgr5* and/or *Lgr5-eGFP-CreER*^*T2*^ alleles are considered as *Lgr5*^+^ cells. Clustering and pseudo-timeline analyses were performed with Cell-Ranger and Monocle2, respectively. Details of the parameter settings are shown in [Table S5](#mmc1){ref-type="supplementary-material"}.

Cartilage Puncture and Repair with Lgr5^+^ Interzone Tissue {#sec4.8}
-----------------------------------------------------------

Lgr5-GFP mice were crossed with *ROSA26*-*tdTomato* mice to generate double heterozygous *Lgr5-GFP*;*tdTomato* embryos. GFP^+^ tissue was dissected from the forming knee joint of E13.5 embryos and transplanted to a lesion punctured with a 27-gauge needle at the trochlear groove of 8-week-old C57bl/6 mice (n = 3, [Figure 6](#fig6){ref-type="fig"}A). Punctured animals without tissue transplant represented the control.
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